8-K

BIODESIX, INC.

Dated: May 23, 2024

/s/ Robin Harper Cowie

Robin Harper Cowie

Chief Financial Officer

0001193125-24-145965.txt : 20240523 0001193125-24-145965.hdr.sgml : 20240523 20240523161006 ACCESSION NUMBER: 0001193125-24-145965 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240521 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 24978280 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 8-K 1 d832577d8k.htm 8-K 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

May 21, 2024

Date of Report (Date of earliest event reported)

Biodesix, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-39659

20-3986492

(State or other jurisdiction
of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


919 West Dillon Rd. Louisville, Colorado		80027
(Address of Principal Executive Office)		(Zip Code)

Registrant’s telephone number, including area code: (303) 417-0500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange

on which registered

Common Stock, par value of $0.001 per share

BDSX

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07.

Submission of Matters to a Vote of Security Holders.

Biodesix, Inc. (the “Company”) held its 2024 annual meeting of stockholders (the “Annual Meeting”) on May 21, 2024. At the Annual Meeting, the Company’s stockholders voted on: (i) the election of three Class I director nominees to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualify, (ii) the ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024, (iii) the approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the conversion of the Company’s Series A Non-Voting Convertible Preferred Stock, par value $0.001 per share (“Series A Preferred Stock”) into shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (iv) the approval, for purposes of complying with Nasdaq Listing Rule 5635(c), of the issuance of the Company’s Series A Preferred Stock to certain of the Company’s directors and officers and any shares of the Company’s common stock issuable upon the conversion thereof.

As of March 25, 2024, the record date for the Annual Meeting, there were 97,159,448 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, all director nominees were elected, the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024 was ratified, the conversion of Series A Preferred Stock into Common Stock was approved and the issuance of Series A Preferred Stock to certain of the Company’s directors and officers and any shares of Common Stock issuable upon conversion thereof was approved. Set forth below are the final voting results for the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting.

At the Annual Meeting, the Company’s stockholders elected, by the vote indicated below, the following three persons as the Class I directors of the Company, each to serve until the 2027 annual meeting of stockholders and until their respective successors are duly elected and qualify:


Name	Votes For		Votes Against		Abstentions		Broker Non-Votes
Jon Faiz Kayyem, Ph.D.		80,125,512		0		2,664,083		6,342,889
Scott Hutton		80,485,516		0		2,304,079		6,342,889
John Patience		79,493,967		0		3,295,628		6,342,889

At the Annual Meeting, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024, by the vote indicated below:


Votes For	Votes Against	Abstentions	Broker Non-Votes
88,308,190	167,344	656,950	0

At the Annual Meeting, the stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(d), the conversion of the Company’s Series A Preferred Stock into shares of the Company’s Common Stock by the vote indicated below:


Votes For	Votes Against	Abstentions	Broker Non-Votes
82,358,525	425,285	5,785	6,342,889

At the Annual Meeting, the stockholders approved, for purposes of complying with Nasdaq Listing Rule 5635(c), the issuance of the Company’s Series A Preferred Stock to certain of the Company’s directors and officers and any shares of the Company’s Common Stock issuable upon the conversion thereof by the vote indicated below:


Votes For	Votes Against	Abstentions	Broker Non-Votes
82,338,086	437,183	14,326	6,342,889

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.


Exhibit No.		Description

104		Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EX-101.SCH 2 bdsx-20240521.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 bdsx-20240521_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period EX-101.PRE 4 bdsx-20240521_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	May 21, 2024
Cover [Abstract]
Entity Registrant Name	BIODESIX INC
Amendment Flag	false
Entity Central Index Key	0001439725
Document Type	8-K
Document Period End Date	May 21, 2024
Entity Incorporation State Country Code	DE
Entity File Number	001-39659
Entity Tax Identification Number	20-3986492
Entity Address, Address Line One	919 West Dillon Rd.
Entity Address, City or Town	Louisville
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80027
City Area Code	(303)
Local Phone Number	417-0500
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Security 12b Title	Common Stock, par value of $0.001 per share
Trading Symbol	BDSX
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - d832577d8k.htm 7 bdsx-20240521.xsd bdsx-20240521_lab.xml bdsx-20240521_pre.xml d832577d8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d832577d8k.htm": { "nsprefix": "bdsx", "nsuri": "http://biodesix.com/20240521", "dts": { "schema": { "local": [ "bdsx-20240521.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "bdsx-20240521_lab.xml" ] }, "presentationLink": { "local": [ "bdsx-20240521_pre.xml" ] }, "inline": { "local": [ "d832577d8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-05-21_to_2024-05-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d832577d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-05-21_to_2024-05-21", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d832577d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://biodesix.com//20240521/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001193125-24-145965-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-145965-xbrl.zip M4$L#!!0 ( $&!MUBH!8/J/@, $$+ 1 8F1S>"TR,#(T,#4R,2YX M (I<%$[-14.N0ZIRQ MX./!JYW]UV$(1R>G%Q#"M3&5S@BYO;V-BBD36O+:6 \ZRF5)( P[_.?+[_"C M\9[!&#E2C5!2;5#!IYKQ(DOC=)#$21JE?9I"ZOQ!00UF,"3I+K' 74C2+/Z0 M#6,X/(=C[T; )2NQSY750K'9M8$W^5OPK",I!'*."SAA@HJ<40[?.LGOX%3D M$1QR#F-'TU:G1G6#1=1ZG>LBT_DUEO35#H!-F-"9L"[K]>^\-8ZMA+/H)7%*]<23.HO+SZ#'F!1ZOD1/F"Q0 ML[DOCTM)/$R3'KA ML1Z.1KS:"9OB#6L.G9V]G :1P/B.T&8W.,/0IGXM<& MAC-/;&/T#UFCW X\(=G;VR/>NB*I,/B@F*S,A/\_/OOD> M"PX< <"W'2LKJ0PTW7;&0 MKK#/$K+LBJV%Z,>ZURU"MWCL](=[_MD96+W(+OX]%W_R?JOXUP;!/U BQ<5+ MQ?2FV?-K(BC+FV'5++>ORQWS1;W93027A^'&@U='2'NJ/Y,*(8T_J*^$5A43 M4]ENV4W7Q%G7R6.<@A]=&56YDAPW#SA2*5FA,LP.][O+T#BX5C@=!6[&A]V< MN>)T$MDYTT'6#KA_O9R96 KRLSMY'=N73N, FWSSGO7 M\S^'6RE\:KB6HNUD]V5[/.JO/=23@W?G7%H$N,7W\>G#;\/R<2"&SJ60Y:(1 M>"3SVKT]W?>A*(Z%E;4XM5VE2B\I &9?D;&%7VT%7PKL)!9H_[$QW[I)[#[V M#UWGH;^DHH#&'?3\[9-5)ZO^:XW%%W'@USGE>[8G57F*S>X7:G?]>;K6;6V)]_ %!+ P04 " !!@;=8@&;H"Y$& "J M1@ %0 &)D?5@O(KAC4G$41[UA_Z '3 08A'Z%@ M1[T-4[T/[U^^>/>#Y\')V?EG\. VCI=J/!C M'C^9?H7?TW1C^,(BYBL&"U_%3,*O*QZ%X]'!Z'!X,!SU1\5ADOE&#T(_9F-X M,QB]'NC US 5&\OEM##\%/T,RZ@2%8%'$ M-G#&A2\"[D=PG9?\"LY%T(?C*((O9IC2=2HF[UC8SU0C+OX=FQ\S4SV\? &@ M3Z-0R;ZCGCD9V;E8SV341SG7Q1X<#O(AO8<1ZYTA]X?)@.';MV\'R=%BM.*V M6"T^'/SYZ>(ZN&4+W].G7[]<099&\;%*]E]@D)S#&@5":83YS>Y,P.SO^C$47>@L2#V.)$:M(; XGV7M9?+Q9ZGBVCID(6:;\71N# M+.I6LIM4U<"72"H6].=X-P@9-X0,NW-A/?U>I_75*AH3#*%*ZGQ:O+2)G[>)\KP=Z[]S[O! M0^[G4JJ>0A2[:%JO&Y*G(N;QY@N;=K_2\^B_QY78(?#>H(77OI:#GH JM% MB(C2[\I@I)WI;*'0(I9UJZ685R'M,1P-;"8 M"ZZ[.D24YL)@E)W1I"^S2&3-6FDPO&*28W@JPA/]P;PICX\&=PRFW0I6!%&@ M:A&D9C9- 3H'F"1D^+90NI7CVO53+!;.18!RB3*Y5'(=ZWP37.FY?3/!L.%G MLCU2G2XDZMG$VD/<%QDUY&F7'%L)(%@-H/^X._F,M6LJ-.J3R1$!3UVNAMU;1%*!._?5YJ-]C M^ U/+XX_A=I2D4X1WF<-:P2[PUTI3$NZ3@7;N6BY;]6*I0F>X(>B)8[#4!M0 MV7\77+!ALW:P"G3:"E66<$^@>PN4BM+BG^F_RC? 9()+0;6.:"%$ M?Z(W+^44[\63P"\.?P[86^S8H'$(T/^L61+P)LT@!),(EK8J0U4H5[/!2'F MR8>"2WDE\8Z+H.%GVS*-YP!\F3$;]8]BR="WZK;$?_KI3J.39Z-M@E:L5'5" M S^$[7"%*O:CO_BR^84>N$S: 6[*5LC;$62M8%%M:4F2#.!3D5Y\:8]&U4- M4-N+XQ>AC$')_"; ;X_IZFM0ML)Q]YC3EZ!V=(C 3=[GC3(-I_1U;GT!JF:Q M;B":;R9&5[ M#>=KC'C 8R[FG_2*6W(_JLNR;61'(%>8P+((%X3+U(CX?9"'7-\9WK9*+I+; MJ&XW;*\D,_W!-!;)MVC,(P+R\N:F_L*A2J$CC&N8PGV1+ECO4R7"6Z>!8AY( M$T&2R1GTMDT4@7^B$U+TSY5:,>G> !:=Y]$&Y0;MS; 33]@2)=IM-4::KM7^ M:,E199K15-@Z+=0)U*WSQP>[U9S+#V$OS1H(X0M9>.EH,N<%J$B,C, ME"&5=J:RA4*+2-:MEF;>/%T'M]HM:_(THGULQ_.GU0B6QU#,H[MZU'-IGH'F M:<3VZK;.J36+I[B_=[I@P2&"OB6#-AHK^.BN.-";YD_L9+MXND?&M%[_@-0 M2P,$% @ 08&W6-I?M3'4! -2P !4 !B9'-X+3(P,C0P-3(Q7W!R M92YX;6S5FEV/XC84AN]7VO_@IC>MU! ",]T.&F9%F9D*E?D0L&W5FY5)#F#5 ML9$=AO#O>QSPBD"8DNFVBKG@P_%[_/H\CN.87'_,$DY>0&DF1=<+&TV/@(AD MS,2\ZZVT3W7$F$=T2D5,N130]3:@O8\W[]]=?^/[Y/9^\$A\LDC3I>X$P7J] M;L0S)K3DJQ1#ZD8DDX#XOJW?GWPBOVV;ZY 1<* :2$)U"HK\O&(\[K2:K7;8 M#%N-UKY, 37Q2$Q3Z)#+H'418,4+$K8ZS0^=RR;I/9"[/(P@$Y; OE8N-XK- M%RGY+OJ>Y*I;*01P#AMRSP05$:.+&+BIG MXJ^.>9L:]^3].X(O3*30>6G7,^G892.;*MZ0:HYVF^W BKQ]378D6K=S27AU M=17D1XOU-2NKC0V$P1\/PW&T@(3Z" &A10=-H9LX_:+>-W<9; _:^IIU=!YI M**,\]V=TBYRL87[YMIIOBORPY;?#1J9C[\8TN!61JL$1&H_>R*^$RE+-P,QDRK)>^&1/*&= MA8)9UYO&.O-M-./EVQ$&^EPE4+I9XDFA6;+DX)%@KR]+A>-&I'GM(184!)"E M(&*(;1C3@?^@MS=;FKLA*Z-"[^U9FZ/2$#7F\B6(@9D6V^:+24T[3PO^^-R7 M.%'TICI5-$J+W>=FC$AE"SF= N]Z):+@:QK:=G<$_1Y:*2875L,0C*XV6Y-*8I]P<@QDH!?%PFX239G.G.)%JR&M^968]'*JQ M&:[WG,[/A74@JB^E Z,63]L9/-MAUL<>*,H'.$%EO\*FVCEU)*XOKA.&+;8+ M9[#9:\ $TW@NK:*FOI"*/BV;'YUC\PSH%2_1\2VN8:M".A#7G]:!88OM@S/8 M[%HJDFHI59[;,:88^G*%T\6FCRNT:O/B/X2J+]*S[%O /SD&^)YQ>%PE4U#5 M:.[KZHYNWZOE=.48IPG-!C&F@BIKZDBCXMFTMGV)@_/_CS0HJ*-PG'NOHR.O9J.;FSR?([^DM! M]&62K,1NC:S/A75"7%]B)PQ;;.YLLHPE9Q%+F9@_X,58,6/M/&9EROH"*W-K M:;FS8_*LP PYP-52OB%K_L!43[/9^=/B:Q'J2^\UUY:B._LI![T9:+T"]>]9 MEL1QAFB)]QW7"WQ M]XN2ZW2!\_N2BHK/+IP(45^"K]JV(-W9"MEU)\-91&AFS&W_1ZY(L41?>X0E MGBV__V&[Y#HXRLL0"\S3KMLCYLT\NXDE?P-02P,$% @ 08&W6%-4%'TM M$P ;*< X !D.#,R-3T=:7/B./9[?H6*WIY)JCAL6Q30+[Z_<]R08;S!&.D/1XJJ:#K>OIZ=U/ MDL__.1I8Y(FZ'N/VIU_5O/(KH;;!368_?OKUHM-LMW_]9^/HO.]#-:AJ>W63 MLD^9ON\[]4)AU'6MO$>-_"-_*D!!05.T8B:H./1R_MBAWJ1V3_>Z>>X^%L*2 M6'6;V_9P,*G\_/R<%]UC ]-W"]BB )5R4(NZS C;C2QF_X@U>RZ*1FJM5BN( MTK#J7,W) )JB% M8W-4]&E;OFMYH4KW+N$D]-LH;?(!PEY2RIDY@\%@2!-"K M6OA^?=4Q^G2@YYCM^;IM3/H?^NY":&H%* TK,H^7-/5T">A!C4F#T:*Z*M2U M8:+T^^?[JVEU/[G^M&K!=W7;ZW%WH/M *MA3.:=H.:T2Z20'I!#K*"2-5?U4 M<\4I+F%PMFRJ,UC$4G.&)(/*E8(L#*HN)A(D[PR2.=5-^.,SWZ*-:N[;>4'^ M/#H?4%\GV#Q'_QJRIT^9)K=]:ONY!R#+##'DTZ>,3T=^0717@%8%V2$AY+S+ MS7'CW&1/Q//'%OV4,9GG6/H8Z9YF&N2I8F[K!;V::U):_HJTOY/V3?.\$(-G#K[IT!<#:IOPO__%TA]?.J:8 M)QL]Y4I5 *"G6QY=-7(B9IHPOJM;;=NDHV]T/(^:N0HOQ(T"+%XJUDZU\CQ\ MA9EE=&F/NB!=J0?/*&SJGA ,,-8^99D8":7GIXS'!HXU>==W<9(HY7*A0,N/ M/#,LUEW#Y4BIJPWSHRD?!U_4 O6*UUD!OV(R*Q9H\,A-?]!AU MB4 A390ZS?:W^ +--D:H$_MW8 6Y.7D$@>/ZE[I/&U/8PI;3LBFLYH*Z8GWZ]5\F=EG MD;H6[?EG ]U]9'8.?]>)/O1Y^,9EC_W@%7;GA)VA+,_UJ2@%B\&9=.%SIQYY M['+?YP/QILM= #U\HSHCXG&+F>2#(O[+-'[YH%:4L_."LVB@XNJ!M(T'BG1; M@D[(_ 1(#Y8FY['_T;I:G3SW] &SQO4'-J >N:'/Y)X/=/M,E#U+N+O<,L\2 MEN?WF_9#ZY)T'BX>6IW%X"BO!$ZGU?S]OOW0;G7(Q2237UX_SDUV32Z61"&9&T7M57HJDOM_?7Y-QS='LBAOK, MISEX8U!0E<^N[F0:"PV(2VX,T7Z(6%@;V \U+2,MN;AV/B\@7(V4>/9 /#MA M=A!']ZV;!W+?NKN]?SB\\+D;NMX0+&CB<]*A!I*?1)A:)-PE:OG8/#D\E+Q' M_#Y% (#73>A@ ,W[ICX>4QW,TZAT*&8:U_I8KJ2F9@GV,B\K#KVLB 1"1?8)?8*:Q!7%=(X04[&V [&FE7:QDG%]2#!BDF.CG'03ZZL\^\;G M( J5)6W;R =*C&Q%H,HNIG7<&ND@7Y"/D2[="=A$]XCG4 /]+9,PFS#?(R"1 M@$S=E$S7(],M\')T[NM=BQ*#6A::71C6S2@9\>SHIAD^!R,%,S6X9>F.1^OA MC^4$0N( 2ERHBO(QP%Q=":"L*Z$S"7"YXE\S[J$62Q\QF! M>**NSPS="I J M)SI;*6BMK=[%E#&2I>:*M4JYMA!Y/R\.'_11.PC;&0)I6R.TDFEH"N"S M6@$7<0V,[D$<5%]%&AP+%D(RB-SP_'1IA(" ?]#>>J?6F_ %MC'?RLI.#+!2]:%_RY H=$ MW4*1G68:-;5&_L PP"6S+*#+>S,_I]%0TJ\'5Q-^WKH/_-G> JIJIG'%A\Q[ M HCFK+WLXJQQ#!*AN6[=.[ FF'4YM M2\^EK&B91DD]A?>*LEY6ZP!K>\-]A M&]OE(]*E%G_&-<-"7-G5?"DRP#)8WF,6BA/F@6SQJ6W"FOL.PK >V-W_&=FAO,/0HO?I" M2JILZAGLU/*?F/M3%V#>UYCQ1=;2[IE$(__C6:)66R1!_W"9#^N%'OK0#CPP M;VN3L,NYU=5AK7R@K*B4+2*^:Z>ETMF\D%VA[6<=9Q)?6K*U!)[9P95I!+@! M9$210YQ(SOI^".12TLH!JDN:7>Z(5E3Q4?(EGF]+O:OKM@"@V M -OVXS4(,I!FUOZ(M_2>B'>*&.A:8F:>+6DYU0M%/)3(H_M?PA)?&5O M6DG)RQY/(C95R@T[XX8[EZ(DQ[W"8H\7*F(7O*H-+..UN:+\GKAB)8D"!G-& M!(4AZ:_2 6MPDIG3CKLGN^4EV6?*3:_!36W/&U+W57BJDO+46CQ5I+G2L;%; MG@KZ7)NG#A 'B)B8TENB+OA;SL*]E"@C0A<*$++88WKSN91T)\R.H[AKQ#<6 M3#&!?PZ:17S ,X5R^Z;1)X:E>][K)'@W1>&A\>7JR)XBN] 9#Z#:L?=**?%7 MP-@^XITWP3Y,06 TT# 'SYYSFP O D1351#766\TV;O0HY?*;:QJ7<'26\3T M3S'].!@ ACH^-WYDB:.[Y$FWAF(9_Z$ X:G$P>.._<3=G4U2EY4:R$(PC&YTS]3_DI1"KG7W M!_7)U=7Q7M 4SC;9MHGE,27=,#!&YAQY_ +]3L>EL)ES./ +V+9C8..@C M>73YL]]'*]O!$+KN$9/VF"TWC,O I5(F\V=;ID=:BN085_OT3 0OP\I,;#5W M<*LY9GW6--6U;FX21UKO/,WJ3D/HT&R?ZS\"9GZOJ;M,HY6,\E\^5-4:N'#+ M=Q&$C7\3;9NRZ=Y<2U4)7,M*@FNY5R2U>TNH$U/2B:3.YI)"?2!D:H%_ X1L M<^'M##TJ:@&^@M037H?!1%9)'@9'_(BQK#$._LQ@:&0*&^"#$I<^,0_: 7OH MMH&A4MTP)J#+PUK[HP1U M29!A9[G9G^UXNTS0!FG:HZ-$=E'I8(Y=\%7$]NI26":PO:QG?>QEY%FCH_/^ MQ$PS<-=4_4--_'<6SL8910-E!0' \N3W;F\K.)J- GZ^O;]LW>>:MU=7%W>= M5CW\\9:C@*J:& 8DXB>0SWQ,:WX74-NG ]Q>HZAGY;QRFI_?L13M[5"1NF7> M0Y D&G:#C=DHLZYU'XC&0Z&FDW]S>1@R-,3(5^@!2O/D)1&QRBXT1_QX'CE& MV8K8UY2SYD33:IIZ=D+ZU#+%83B4B"#A[2'( M(10[[[RA85#/XUC+I<0<6N.)DL5F?T&_K =J^IA%(4=E--FW'6@]W7$XLWT, M].*K;W?7OX$=?8?V9Q*"0.]3![6V.&D;"69V+="/$37<8^Y J''L!8\<$VB% M!9?4H+CY2X)5#%9)@,I.IEM=P._+BO:@O!WN4;$+<<8D"'R *X "WPG3MEPI MXBGT;#@_4,?!S6[AF]DI=4")HAV]VH"]X78.& W#,('IVA2]^PR%[)VX^ >Q M,>>^SOJN:*@+.IZ,/=-X0M&P-%RV\1;!;TB?V5M[T*B3'0Z4%71SS)XBY++] M.AC3=0"Y-<0;RU:NP@PFD'L,0+'.%BY@R'&29;C8E1H\H-&X/O8DD+B60P?> MS9 /^G"4]_)+3AK+@^[;"M +3XIWU^@'HJP<,HDTK@W0P 2/]$\8+$&VP8(_ MXS^UTZQ:KF5+I>I+,1$($S[TA4TM]I_"L[@FRI([QE!$$CU)OBX4NV#;)LA( M 6H@PK)O23"19QA0"LX0LKA(64BX@G6CO":ZDDP5H':6,5Z#"6(0Q0E^GMAC M(.7 MQ+-@.G%-F$Q@>]M)^![MY-+'Q;&^X%S2&H:TFG]C1O&<#;RI,3>1+5VYH540 M7QC%,"4]9V=VK4KK#A2HAPGO4/ D&7NS0C4KLPX'L_SJJ\W^F>M9]IE'W@T_ M22JN:8OSR$=',I-\E$3]973!C];.!I#9/^^OC]+"/EXEJ[U11GHM2;)& M9I*$5\P*BLTAA6Z5TY-YQ0T2KW/"V>#(.R!@M8D0#N) ,_LO-DB\K@B(8+3 MPU,#NSJ[];YF+@&Z>-3Q&N6_'0HNNAY>TXR;N/YVIM M?[>(D+.!>MII;O^LJQL_'EUP;LQ<$(4& X'V>LME\$9V6S3JC&N"07)AGS'A M=M5SX;O_ F_CB\[^1[[AU72#++GKYR_SNQ"P"Y=Y$?%LW4-(SB(,C^># MLRKX[F70GH6%9">I[N2&.\9%^]$>OX,YFG?)G>Z MS_ XS$\A5T]KV5*MF*U53E,^2N4JX*"8U6KE;$6KIKC8CUP]VE/X_6^?KM+> M<[HJEO(),\QO*?6]-%?VH@S3Q@G9UTHP30\J5I><4UR67])*:^:7D@\9KMU\ MQ6%%[85IKH7]E/9_Z'&WL=^W=\0QDF79YIC>KD/D;P GD]1+BI< +[&D3(J5 M "LR&[/VQLQ(IB:JFMY0WF7&Z SG6:UFBTHUJ]82W)%=V-M)LG$6!K5R"K9O MZ7 5,J5;*U\0 PHJ<6^=XN]^--8[.&NR.UVJ;]PBWKB'M/EVWIC^SU3@SXU MZ%.#/C7H4X,^->A3@WZ/!KV6+9:KV3)^UZ@$!*&=/#SE\/)2? MFO7[-.M+J5D?._3XED\\+CD EGSB,?4:4J\A]1I2KR'U&E*O(?4:]NPU%*M9 MI9JPX_75O(;B:59-VJ#^:GF(4K:H'1 !2]V&H^B%4D!/Z9U2[]'GV?&=4K6\ MHK[;.Z6^3.[0$Q^:Q#U'TI%HC?JLR_Q#W"!U;)[,#/].SZVO>?]YW*'8[&1W MG,)KQ5>[LWQC0;O/P][,%O<*=BWP<7=NC@2D*:[BON&[/*KXDYV4OZ2>X3+' M9Y$324FF6(2EY\@K_/X?%!06ED2/%+_6-Y/G17GB0JG*2[=4K$D<0G*SZ<U$QCL5DU*0N8&) ML-ZET.&-9;'K@,6E-88^],1V9^8%WQC%8;I@5\)DQ;6+XF+(+NWKUB0"*;X8 M$U3 V.00MS^([F!I^MR%B9GOVF!8]/'YY4''THZBAMO%+G<46J"115%< M)>^VVD$4?+A"EYC\J$?NF2W*TQ+[B5CLEFR$S?!Y7-\3K"^,$JZXQ_N%VJK@ M%>!G%^R9K[J+EYXV^3.C<;OS4#2ST>&X U<7M()W7>V-6I)6*UVI#5=*?'QG M;TO5[#/:(]-8T:U,.:_C'YP7NMP"TR,#(T,#4R,2YX M"TR,#(T,#4R,5]L86(N>&UL4$L! A0#% @ 08&W6-I?M3'4 M! -2P !4 ( !,0H &)D XML 17 d832577d8k_htm.xml IDEA: XBRL DOCUMENT 0001439725 2024-05-21 2024-05-21 BIODESIX INC false 0001439725 8-K 2024-05-21 DE 001-39659 20-3986492 919 West Dillon Rd. Louisville CO 80027 (303) 417-0500 false false false false Common Stock, par value of $0.001 per share BDSX NASDAQ true false